These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30503227)

  • 1. ypT0N+ status in oesophageal cancer patients: Location of residual metastatic lymph nodes with regard to the neoadjuvant radiation field.
    Schurink B; Seesing MFJ; Goense L; Mook S; Brosens LAA; Mohammad NH; Ruurda JP; Roeling TAP; Bleys RLAW; van Hillegersberg R
    Eur J Surg Oncol; 2019 Mar; 45(3):454-459. PubMed ID: 30503227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
    Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
    J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual nodal involvement after complete tumor response in patients undergoing neoadjuvant (chemo)radiotherapy for rectal cancer.
    Erkan A; Mendez A; Trepanier M; Kelly J; Nassif G; Albert MR; Lee L; Monson JRT
    Surgery; 2019 Oct; 166(4):648-654. PubMed ID: 31378480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?
    Depypere LP; Vervloet G; Lerut T; Moons J; De Hertogh G; Sagaert X; Coosemans W; Van Veer H; Nafteux PR
    J Thorac Dis; 2018 May; 10(5):2771-2778. PubMed ID: 29997939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
    Wang Q; Yu S; Xiao Z; Liu X; Zhang W; Zhang X; He J; Sun K; Xu T; Feng Q; Zhou Z; Wang L; Yin W
    Radiat Oncol; 2015 Jul; 10():142. PubMed ID: 26159510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of metastatic lymph node number and ratio in oesophageal squamous cell carcinoma patients with or without neoadjuvant chemoradiation.
    Chien HC; Chen HS; Wu SC; Hsu PK; Liu CY; Wang BY; Shih CH; Liu CC
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):337-43. PubMed ID: 26893382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic nodal clearance and complete response following neoadjuvant chemoradiation for clinical N2 non-small cell lung cancer: Predictors and long-term outcomes.
    Haque W; Verma V; Butler EB; Teh BS
    Lung Cancer; 2019 Apr; 130():93-100. PubMed ID: 30885358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
    Yeo SG; Kim DY; Kim TH; Chang HJ; Oh JH; Park W; Choi DH; Nam H; Kim JS; Cho MJ; Kim JH; Park JH; Kang MK; Koom WS; Kim JS; Nam TK; Chie EK; Kim JS; Lee KJ
    Ann Surg; 2010 Dec; 252(6):998-1004. PubMed ID: 21107110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy.
    Giugliano DN; Berger AC; Pucci MJ; Rosato EL; Evans NR; Meidl H; Lamb C; Levine D; Palazzo F
    J Gastrointest Surg; 2017 Sep; 21(9):1377-1384. PubMed ID: 28664255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma.
    Park SY; Lee J; Oh D; Sun JM; Yun J; Jeon YJ; Cho JH; Choi YS; Zo JI; Shim YM; Kim HK
    Esophagus; 2024 Jan; 21(1):51-57. PubMed ID: 38082188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
    Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
    Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of remaining tumour involved lymph nodes with MRI in patients with complete luminal response after neoadjuvant treatment of rectal cancer.
    Loftås P; Sturludóttir M; Hallböök O; Almlöv K; Arbman G; Blomqvist L
    Br J Radiol; 2018 Jul; 91(1087):20170938. PubMed ID: 29668301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy.
    Lee H; Ahn YC; Pyo H; Kim B; Oh D; Nam H; Lee E; Sun JM; Ahn JS; Ahn MJ; Park K; Choi YS; Kim J; Zo JI; Shim YM
    Ann Surg Oncol; 2014 Jun; 21(6):2083-90. PubMed ID: 24522994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study.
    Al-Kaabi A; van der Post RS; van der Werf LR; Wijnhoven BPL; Rosman C; Hulshof MCCM; van Laarhoven HWM; Verhoeven RHA; Siersema PD
    Acta Oncol; 2021 Apr; 60(4):497-504. PubMed ID: 33491513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
    Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM
    Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.